India to Maldives: Adalimumab Export Trade Route
India has recorded 12 verified shipments of Adalimumab exported to Maldives, representing a combined trade value of $14.1K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $1.2K USD. The leading Indian exporter is MEDIX, which accounts for 47% of total export value with 4 shipments worth $6.7K USD. On the buying side, STATE TRADING ORGANIZATION PLC is the largest importer in Maldives with $6.7K USD in purchases. The top 3 suppliers — MEDIX, NU HOSPITALS PRIVATE LIMITED, FEDELTY HEALTHCARE PRIVATE LIMITED — together control 88% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Maldives Adalimumab corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $14.1K USD. The route is dominated by MEDIX, which alone accounts for roughly 47% of all export value, reflecting the consolidated nature of India's adalimumab manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with adalimumab's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #18 among India's top adalimumab export destinations globally.
On the import side, key buyers of Indian adalimumab in Maldives include STATE TRADING ORGANIZATION PLC, INDIRA GANDHI MEMORIAL HOSPITAL, TO THE ORDER- and 3 others. STATE TRADING ORGANIZATION PLC is the single largest importer with 4 shipments valued at $6.7K USD.
